We are live on
!
Find out more
FNBOO
First National Bank of Omaha Portfolio holdings
AUM
$3.55B
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.97%
1 Year Est. Return
+27.24%
3 Year Est. Return
+70.89%
5 Year Est. Return
+96.41%
10 Year Est. Return
+340.36%
AUM
$1.65B
AUM Growth
+$31.8M
(+2%)
Cap. Flow
-$37.7M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
21.27%
Holding
342
New
12
Increased
71
Reduced
207
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robert Half
RHI
|
+$6.02M |
| 2 |
Abbott
ABT
|
+$5.92M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$5.72M |
| 4 |
Cintas
CTAS
|
+$1.59M |
| 5 |
InMode
INMD
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$6.11M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
+$4.93M |
| 3 |
Labcorp
LH
|
+$3.78M |
| 4 |
Apple
AAPL
|
+$2.45M |
| 5 |
Microsoft
MSFT
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.97% |
| 2 | Financials | 13.16% |
| 3 | Healthcare | 11.99% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Staples | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Oshkosh
OSK
$9.61B
| $1.35M | 0.08% |
16,173
+513
| +3% | +$46.5K |
|
202
AbbVie
ABBV
$440B
| $1.31M | 0.08% |
8,195
-339
| -4% | -$51.8K |
|
203
UMB Financial
UMBF
$11.4B
| $1.23M | 0.07% |
21,360
+782
| +4% | +$63.6K |
|
204
Comfort Systems
FIX
$61.2B
| $1.21M | 0.07% |
8,309
-333
| -4% | -$43.2K |
|
205
iShares Russell Mid-Cap ETF
IWR
$57.9B
| $1.21M | 0.07% |
17,262
-491
| -3% | -$34.7K |
|
206
Sherwin-Williams
SHW
$87.4B
| $1.14M | 0.07% |
5,069
+3,730
| +279% | +$854K |
|
207
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $1.13M | 0.07% |
14,828
-3,684
| -20% | -$279K |
|
208
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $1.07M | 0.07% |
7,428
+700
| +10% | +$103K |
|
|
209
Labcorp
LH
$26.2B
| $1.04M | 0.06% |
5,288
-18,389
| -78% | -$3.78M |
|
210
Integer Holdings
ITGR
$4.25B
| $1.01M | 0.06% |
12,985
-2,497
| -16% | -$183K |
|
211
Pacira BioSciences
PCRX
$945M
| $1M | 0.06% |
24,595
+254
| +1% | +$10.1K |
|
212
Clorox
CLX
$12.8B
| $948K | 0.06% |
5,989
-50
| -0.8% | -$7.5K |
|
213
Onto Innovation
ONTO
$20.6B
| $893K | 0.05% |
10,162
-398
| -4% | -$32.3K |
|
214
Shell
SHEL
$249B
| $882K | 0.05% |
15,321
-2,710
| -15% | -$159K |
|
215
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.93B
| $827K | 0.05% |
9,768
| – | – |
|
216
Kforce
KFRC
$1.03B
| $823K | 0.05% |
13,013
+607
| +5% | +$36.1K |
|
217
Vanguard FTSE All-World ex-US ETF
VEU
$70.5B
| $815K | 0.05% |
15,251
+57
| +0.4% | +$3.02K |
|
218
Cigna
CI
$73.3B
| $802K | 0.05% |
3,137
-4
| -0.1% | -$1.17K |
|
219
Enpro
NPO
$7.23B
| $784K | 0.05% |
7,544
-498
| -6% | -$54.5K |
|
|
PR
220
Permian Resources
PR
$18B
| $763K | 0.05% |
72,696
-2,901
| -4% | -$29.6K |
|
221
Emerson Electric
EMR
$91.4B
| $753K | 0.05% |
8,641
-300
| -3% | -$26.2K |
|
222
Marcus & Millichap
MMI
$1.18B
| $740K | 0.04% |
23,041
+3,770
| +20% | +$131K |
|
223
Monarch Casino & Resort
MCRI
$2.22B
| $731K | 0.04% |
9,858
-1,749
| -15% | -$133K |
|
|
CSW
224
CSW Industrials
CSW
$5.65B
| $714K | 0.04% |
5,136
+612
| +14% | +$82.6K |
|
225
Advanced Energy
AEIS
$13.5B
| $709K | 0.04% |
7,231
-292
| -4% | -$27.5K |
|
Similar funds
TYCC
WWA
VPC
BPS
BCP
TCM
SL
ACM
First National Bank of Omaha's Q1 2023 Portfolio in Review
As of Q1 2023, First National Bank of Omaha held 342 positions worth $1.65B, up 2% from $1.62B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
First National Bank of Omaha's Q1 2023 filing shows 12 new, 71 increased, 207 reduced and 12 closed positions. Its largest new stake was Jazz Pharmaceuticals: 38,689 shares worth $5.66M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $6.11M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- First National Bank of Omaha's largest Q1 2023 buy was Jazz Pharmaceuticals: 38,689 shares worth $5.66M.
- First National Bank of Omaha added most to Robert Half in Q1 2023, an estimated $6.02M increase.
- First National Bank of Omaha's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $6.11M.
- First National Bank of Omaha fully exited LHC Group LLC in Q1 2023, selling an estimated $4.93M.
- First National Bank of Omaha's ten largest holdings make up 21% of its $1.65B portfolio in Q1 2023.
- First National Bank of Omaha opened 12 new positions and closed 12 in Q1 2023.
- First National Bank of Omaha's portfolio value rose 2% quarter-over-quarter to $1.65B.
Based on First National Bank of Omaha's 13F filing for Q1 2023, filed 3 May 2023.